Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells

Liver International

Volumn 29, Issue 10, 2009, Pages 1569-1581

  Huang, Jiayi ^a,b   Bi, Yang ^a,b   Zhu, Gao Hui ^a,b   He, Yun ^a,b   Su, Yuxi ^a,b   He, Bai Cheng ^a,b   Wang, Yi ^a,b   Kang, Quan ^a,b   Chen, Liang ^a,b   Zuo, Guo Wei ^a,b   Luo, Qing ^a,b   Shi, Qiong ^a,b   Zhang, Bing Qiang ^a,b   Huang, Ailong ^a   Feng, Lan Zhou ^a,b   Luu, Hue H ^b   Haydon, Rex C ^b   He, Tong Chuan ^a,b   Tang, Ni ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Hepatic differentiation; Hepatic progenitor cells; Nuclear receptors; Retinoid signalling; Signalling transduction

Indexed keywords

ALPHA FETOPROTEIN; CYTOKERATIN 18; HISTONE ACETYLTRANSFERASE PCAF; NUCLEAR RECEPTOR COREPRESSOR; RECEPTOR INTERACTING PROTEIN 140; RETINAL DEHYDROGENASE; RETINAL DEHYDROGENASE 1; RETINAL DEHYDROGENASE 2; RETINAL DEHYDROGENASE 3; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FETUS; GLYCOGEN SYNTHESIS; IMMUNOFLUORESCENCE; LIVER CELL; LIVER DEVELOPMENT; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; LIVER; MICE; NUCLEAR RECEPTOR CO-REPRESSOR 1; NUCLEAR RECEPTOR COACTIVATOR 1; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION; STEM CELLS; TRETINOIN;

EID: 73349127810     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02111.x     Document Type: Article

References (68)

1. Zaret K.S. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet 2002; 3: 499-512.
2. Zaret K.S. Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet 2008; 9: 329-40.
3. Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008; 322: 1490-4.
4. Thompson MD, Monga S.P. WNT/beta-catenin signaling in liver health and disease. Hepatology 2007; 45: 1298-305.
5. Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res 2008; 331: 271-82.
6. Fausto N, Campbell J.S. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120: 117-30.
7. Oertel M, Shafritz D.A. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008; 1782: 61-74.
8. Walkup MH, Gerber D.A. Hepatic stem cells: in search of. Stem Cells 2006; 24: 1833-40.
9. Schmelzer E, Wauthier E, Reid L.M. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 2006; 24: 1852-8.
10. Kitisin K, Shetty K, Mishra L, Johnson L.B. Hepatocellular stem cells. Cancer Biomark 2007; 3: 251-62.
11. Fiegel HC, Lange C, Kneser U, et al. Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med 2006; 10: 577-87.
12. Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy. Semin Cell Dev Biol 2007; 18: 819-26.
13. Strick-Marchand H, Weiss M.C. Inducible differentiation and morphogenesis of bipotential liver cell lines from wildtype mouse embryos. Hepatology 2002; 36: 794-804.
14. Monga SP, Tang Y, Candotti F, et al. Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explants. Cell Transpl 2001; 10: 81-9.
15. Sgodda M, Aurich H, Kleist S, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Exp Cell Res 2007; 313: 2875-86.
16. Yoshida Y, Shimomura T, Sakabe T, et al. A role of Wnt/ beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1089-98.
17. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008; 134: 921-31.
18. Niederreither K, Dolle P. Retinoic acid in development: towards an integrated view. Nat Rev Genet 2008; 9: 541-53.
19. Ziouzenkova O, Orasanu G, Sharlach M, et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 2007; 13: 695-702.
20. Mark M, Ghyselinck NB, Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 2006; 46: 451-80.
21. Chawla A, Repa JJ, Evans RM, Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294: 1866-70.
22. Mic FA, Haselbeck RJ, Cuenca AE, Duester G. Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice. Development 2002; 129: 2271-82.
23. Germain P, Iyer J, Zechel C, Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 2002; 415: 187-92.
24. Collingwood TN, Urnov FD, Wolffe A.P. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 1999; 23: 255-75.
25. Westerman KA, Leboulch P. Reversible immortalization of mammalian cells mediated by retroviral transfer and sitespecific recombination. Proc Natl Acad Sci USA 1996; 93: 8971-6.
26. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25: 3818-22.
27. Libbrecht L. Hepatic progenitor cells in human liver tumor development. World J Gastroenterol 2006; 12: 6261-5.
28. Luo Q, Kang Q, SiW, et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 55958-68.
29. Luo X, Chen J, Song WX, et al. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 2008; 88: 1264-77.
30. Peng Y, Kang Q, Cheng H, et al. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 2003; 90: 1149-65.
31. Peng Y, Kang Q, Luo Q, et al. Inhibitor of DNA binding/ differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 32941-9.
32. Si W, Kang Q, Luu HH, et al. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 2006; 26: 2955-64.
33. Tang N, Song WX, Luo J, et al. BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/b-catenin signaling. J Cell Mol Med 2008 Nov 3. [Epub ahead of print] DOI: 10.1111/j.1582-4934.2008.00569.x.
34. Kang Q, Song WX, Luo Q, et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009; 18: 545-59.
35. Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 11: 1312-20.
36. Luu HH, Kang Q, Park JK, et al. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 2005; 22: 319-29.
37. Sharff KA, Song WX, Luo X, et al. Hey1 basic helix-loophelix (bHLH) protein plays an important role in mediating BMP9 induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem 2009; 284: 649-59.
38. Schmitt TM, Ciofani M, Petrie HT, Zuniga-Pflucker J.C. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 2004; 200: 469-79.
39. Hirano K, Shishido-Hara Y, Kitazawa A, et al. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation. Pathol Res Pract 2008; 204: 799-807.
40. Moon YJ, Lee MW, Yoon HH, et al. Hepatic differentiation of cord blood-derived multipotent progenitor cells (MPCs) in vitro. Cell Biol Int 2008; 32: 1293-301.
41. Levesque E, Girard H, Journault K, Lepine J, Guillemette C. Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 2007; 45: 128-38.
42. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001; 33: 738-50.
43. Ijpenberg A, Perez-Pomares JM, Guadix JA, et al. Wt1 and retinoic acid signaling are essential for stellate cell development and liver morphogenesis. Dev Biol 2007; 312: 157-70.
44. Sucov HM, Dyson E, Gumeringer CL, et al. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994; 8: 1007-18.
45. Perez-Pomares JM, Carmona R, Gonzalez-Iriarte M, et al. Contribution of mesothelium-derived cells to liver sinusoids in avian embryos. Dev Dyn 2004; 229: 465-74.
46. Jacob A, Budhiraja S, Qian X, et al. Retinoic acid-mediated activation of HNF-3 alpha during EC stem cell differentiation. Nucleic Acids Res 1994; 22: 2126-33.
47. Hatzis P, Talianidis I. Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression. Mol Cell Biol 2001; 21: 7320-30.
48. Jacob A, Budhiraja S, Reichel R.R. The HNF-3alpha transcription factor is a primary target for retinoic acid action. Exp Cell Res 1999; 250: 1-9.
49. Sato T, Kato R, Tyson C.A. Regulation of differentiated phenotype of rat hepatic lipocytes by retinoids in primary culture. Exp Cell Res 1995; 217: 72-83.
50. Hu Z, Fujio K, Marsden ER, Thorgeirsson SS, Evarts R.P. Hepatic regeneration in vitamin A-deficient rats: changes in the expression of transforming growth factor alpha/epidermal growth factor receptor and retinoic acid receptors alpha and beta. Cell Growth Differ 1994; 5: 503-8.
51. Wang K, Chen S, Xie W, Wan Y.J. Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway. Biochem Pharmacol 2008; 75: 2204-13.
52. Ledda-Columbano GM, Pibiri M, Molotzu F, et al. Induction of hepatocyte proliferation by retinoic acid. Carcinogenesis 2004; 25: 2061-6.
53. Park BH, Breyer B, He T.C. Peroxisome proliferatoractivated receptors: roles in tumorigenesis and chemoprevention in human cancer. Curr Opin Oncol 2001; 13: 78-83.
54. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003; 22: 7305-15.
55. Karamouzis MV, Konstantinopoulos PA, Papavassiliou A.G. The molecular basis of retinoids' use in breast cancer chemoprevention. Cell Oncol 2007; 29: 183-4.
56. Lotan R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J Natl Cancer Inst 1995; 87: 1655-7.
57. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996; 10: 1031-9.
58. Okuno M, Kojima S, Matsushima-Nishiwaki R, et al. Retinoids in cancer chemoprevention. Curr Cancer Drug Targets 2004; 4: 285-98.
59. Shen P.F. Molecular mechanisms of chemoprevention and therapy of cancer by retinoids. Front Biosci 2004; 9: 2663-70.
60. Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 2002; 41: 41-55.
61. Verma A.K. Retinoids in chemoprevention of cancer. J Biol Regul Homeost Agents 2003; 17: 92-7.
62. Zusi FC, Lorenzi MV, Vivat-Hannah V. Selective retinoids and rexinoids in cancer therapy and chemoprevention. Drug Discov Today 2002; 7: 1165-74.
63. Soprano DR, Soprano K.J. Retinoids as teratogens. Annu Rev Nutr 1995; 15: 111-32.
64. Collins MD, Mao G.E. Teratology of retinoids. Annu Rev Pharmacol Toxicol 1999; 39: 399-430.
65. Lin RJ, Egan DA, Evans R.M. Molecular genetics of acute promyelocytic leukemia. Trends Genet 1999; 15: 179-84.
66. Haydon RC, Luu HH, He T.C. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clin Orthop Relat Res 2007; 454: 237-46.
67. Haydon RC, Zhou L, Feng T, et al. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 2002; 8: 1288-94.
68. Fields AL, Soprano DR, Soprano KJ. Retinoids in biological control and cancer. J Cell Biochem 2007; 102: 886-98.